Lab
Salud Integral En LA Montana, INC
Salud Integral En LA Montana, INC was paid $3.65M by Medicaid between Jan 2018 and Nov 2024, across 109 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 11% of everything it billed.
33Billing provider infoSALUD INTEGRAL EN LA MONTANA, INC
NARANJITO, PR 00719
NARANJITO, PR 00719
33aNPI1609882869assigned 07/31/2006
33bProvider typeClinical Medical Laboratory
28Total paid$3.65M
24GClaims377,701
24DCodes billed109
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#17 of 777
Median peer was paid$278K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,520 | $54K | |
| 2019 | 50,500 | $502K | |
| 2020 | 34,567 | $464K | |
| 2021 | 42,114 | $508K | |
| 2022 | 49,766 | $532K | |
| 2023 | 74,211 | $699K | |
| 2024incomplete | 66,023 | $890K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 32,402 | 29,597 | $390K |
| 80061 | Lipid panel | 10% | 36,438 | 33,351 | $367K |
| 80053 | Comprehensive metabolic panel | 8.1% | 37,985 | 34,459 | $295K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.8% | 9,596 | 8,757 | $285K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.9% | 45,025 | 40,566 | $253K |
| 80074 | 6.1% | 5,415 | 4,817 | $223K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.1% | 10,261 | 9,272 | $221K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.2% | 5,579 | 4,924 | $189K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.3% | 22,018 | 20,098 | $158K |
| 82274 | 3.8% | 12,154 | 11,133 | $138K | |
| 86703 | 3.8% | 14,551 | 13,377 | $138K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 2,535 | 2,313 | $118K |
97 more codes
| 81000 | 2.7% | 39,688 | $97K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 2,065 | $70K |
| 84153 | 1.8% | 4,729 | $64K | |
| 84439 | 1.6% | 8,541 | $57K | |
| 86803 | 1.3% | 4,026 | $46K | |
| 82607 | 1.2% | 3,434 | $43K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.0% | 6,093 | $37K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,686 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,195 | $31K |
| 82570 | <1% | 5,642 | $25K | |
| 82044 | <1% | 8,071 | $24K | |
| 82043 | <1% | 4,502 | $23K | |
| 86038 | <1% | 2,229 | $20K | |
| 86592 | <1% | 6,154 | $19K | |
| 86800 | <1% | 1,174 | $14K | |
| 80050 | General health panel | <1% | 2,378 | $13K |
| 85730 | <1% | 2,831 | $13K | |
| 84154 | <1% | 889 | $12K | |
| 82728 | <1% | 939 | $11K | |
| 80069 | <1% | 1,590 | $11K | |
| 83001 | <1% | 752 | $11K | |
| 85651 | <1% | 3,795 | $10K | |
| 86140 | <1% | 2,290 | $10K | |
| 86160 | <1% | 719 | $10K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,033 | $9K |
| 86738 | <1% | 767 | $9K | |
| 85610 | <1% | 3,069 | $9K | |
| 86376 | <1% | 865 | $9K | |
| 84146 | <1% | 561 | $9K | |
| 87536 | <1% | 138 | $8K | |
| 84403 | <1% | 336 | $8K | |
| 86235 | <1% | 249 | $7K | |
| 84156 | <1% | 2,243 | $6K | |
| 86225 | <1% | 558 | $5K | |
| 83550 | <1% | 702 | $5K | |
| 83880 | <1% | 167 | $5K | |
| 83540 | <1% | 927 | $5K | |
| 84703 | <1% | 884 | $5K | |
| 82670 | <1% | 201 | $5K | |
| 83655 | <1% | 755 | $5K | |
| 84550 | <1% | 1,401 | $5K | |
| 86431 | <1% | 1,024 | $5K | |
| 82746 | <1% | 419 | $4K | |
| 86256 | <1% | 323 | $4K | |
| 82951 | <1% | 492 | $4K | |
| 83002 | <1% | 257 | $3K | |
| 86361 | <1% | 137 | $3K | |
| 83970 | <1% | 61 | $2K | |
| 87340 | <1% | 246 | $2K | |
| 82950 | <1% | 697 | $2K | |
| 84480 | <1% | 242 | $2K | |
| 84481 | <1% | 207 | $2K | |
| 82947 | <1% | 1,000 | $2K | |
| 86706 | <1% | 151 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 32 | $2K |
| 86704 | <1% | 126 | $2K | |
| 82952 | <1% | 795 | $2K | |
| 80076 | <1% | 304 | $2K | |
| 82565 | <1% | 274 | $1K | |
| 82785 | <1% | 130 | $1K | |
| 86696 | <1% | 184 | $1K | |
| 84144 | <1% | 44 | $989.22 | |
| 84520 | <1% | 299 | $979.11 | |
| 84436 | <1% | 279 | $930.57 | |
| 82550 | <1% | 178 | $839.14 | |
| 83735 | <1% | 128 | $726.71 | |
| 86200 | <1% | 81 | $599.74 | |
| 86430 | <1% | 119 | $596.08 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 22 | $573.60 |
| 87338 | <1% | 45 | $498.90 | |
| 84432 | <1% | 24 | $372.84 | |
| 82150 | <1% | 71 | $317.16 | |
| 82627 | <1% | 13 | $306.93 | |
| 82378 | <1% | 12 | $232.24 | |
| 86762 | <1% | 38 | $213.66 | |
| 83690 | <1% | 61 | $172.83 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 158 | $152.30 |
| 84460 | <1% | 99 | $152.11 | |
| 83525 | <1% | 13 | $147.96 | |
| 87070 | <1% | 15 | $123.28 | |
| 86677 | <1% | 82 | $122.78 | |
| 82575 | <1% | 13 | $113.30 | |
| 84450 | <1% | 90 | $106.64 | |
| 82105 | <1% | 42 | $79.50 | |
| 87177 | <1% | 197 | $77.30 | |
| 83615 | <1% | 12 | $75.03 | |
| 82677 | <1% | 12 | $57.31 | |
| 84702 | <1% | 31 | $57.02 | |
| 86886 | <1% | 48 | $49.08 | |
| 84100 | <1% | 12 | $43.30 | |
| 86336 | <1% | 12 | $36.93 | |
| 84479 | <1% | 25 | $33.68 | |
| 86900 | <1% | 28 | $10.98 | |
| 86580 | <1% | 32 | $7.58 | |
| 82270 | 0% | 14 | $0.00 | |
| 86695 | 0% | 12 | $0.00 | |
| 85044 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, SANDRA (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Salud Integral En LA Montana, INC | Corozal, PR | $2.13M |
| Sandra Patricia Garcia DPM PC | Bronx, NY | $204K |
| Sandra Patricia Garcia DPM PC | Flushing, NY | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.